TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33436658

Group type: EXPERIMENTAL
Intervention: Group B Streptococcus (GBS) colonization in pregnant women
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: Invasive GBS infections in infants
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: Type III GBS in infants with invasive infections
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: Type V GBS in colonized adults and non-invasive infections
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: Hypervirulent clone III/ST17 association with invasive infections
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: GBS resistance to erythromycin
Number of subjects: 5621

Group type: EXPERIMENTAL
Intervention: GBS resistance to clindamycin
Number of subjects: 5621
Study: 33369860

Group type: EXPERIMENTAL
Intervention: Two-day event with webinars and randomised coffee trial meetings
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Networking opportunities provided during the event
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Virtual aspects of the event
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Future events
Number of subjects: 100
Study: 32974752

Group type: EXPERIMENTAL
Intervention: Greater Curvature (GC) group
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lesser Curvature (LC) group
Number of subjects: 70
Study: 32785210

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: 20 mg rosuvastatin
Number of subjects: 323
Study: 33965884

Group type: EXPERIMENTAL
Intervention: Epley manoeuvre (EM)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Sham manoeuvre
Number of subjects: 134
Study: 32456614

Group type: EXPERIMENTAL
Intervention: Integrated global care program (PEPCI)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2
Study: 34192768

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (no KMC)
Number of subjects: 73
Study: 33602994

Group type: EXPERIMENTAL
Intervention: Real-time brain activity manipulation during 3D-MOT training over 10 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active sham-control group
Number of subjects: 0
Study: 32487131

Group type: EXPERIMENTAL
Intervention: Dietary plant sterols (PS) intervention: 2 daily portions of margarine providing 1 g PS each (2.0 g/day total) for 4 weeks.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo treatment: Identical margarine containing no added PS for 4 weeks.
Number of subjects: 64
Study: 34894776

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 23
Study: 33144332

Group type: EXPERIMENTAL
Intervention: Routine donor milk use
Number of subjects: 458

Group type: COMPARATOR
Intervention: Hospitals with ≥1500 annual births
Number of subjects: 458

Group type: COMPARATOR
Intervention: Hospitals with ≤500 annual births
Number of subjects: 458

Group type: COMPARATOR
Intervention: Hospitals in the west
Number of subjects: 458
Study: 34674024

Group type: EXPERIMENTAL
Intervention: DJ-5 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: DJ-20 s
Number of subjects: 12
Study: 32548941

Group type: EXPERIMENTAL
Intervention: 4.0% IPA emulsion
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo emulsion
Number of subjects: 64
Study: 35098971

Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention (nutritional guidance, exercise, cognitive training, vascular/metabolic risk management and social stimulation)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention + medical food (Fortasyn Connect)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Regular health advice/care (control group)
Number of subjects: 93
Study: 33739797

Group type: EXPERIMENTAL
Intervention: Sequential embryo transfer on days 3 and 5
Number of subjects: 210

Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 210

Group type: COMPARATOR
Intervention: Day 5 (blastocyst) transfer
Number of subjects: 210
Study: 35088708

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 54
Study: 32889846

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 70
Study: 33591115

Group type: EXPERIMENTAL
Intervention: NO‐NPO group (400 mL carbohydrate drink at midnight and freely up to 2 hours before anesthesia)
Number of subjects: 64

Group type: COMPARATOR
Intervention: NPO group (fasted until surgery)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: NO‐NPO group
Number of subjects: 64

Group type: COMPARATOR
Intervention: NPO group
Number of subjects: 64
Study: 32701144

Group type: EXPERIMENTAL
Intervention: Welch Allyn Mobil‐O‐Graph (WA)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Sun Tech Classic Oscar2 (STO)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Spacelabs 90227 (SL)
Number of subjects: 365

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 365
Study: 36368749

Group type: EXPERIMENTAL
Intervention: Donor-derived modified immune cells (MIC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard-of-care (SoC)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MIC treatment
Number of subjects: 63
Study: 33497765

Group type: EXPERIMENTAL
Intervention: Anodal stimulation over the right dlPFC and cathodal stimulation over the left supraorbital
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Cathodal stimulation over the right dlPFC and anodal stimulation over the left supraorbital
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 92
Study: 32865376

Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 665

Group type: COMPARATOR
Intervention: Aspirin plus clopidogrel
Number of subjects: 665
Study: 36014843

Group type: EXPERIMENTAL
Intervention: 3-month moderate exercise program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cultural activities (control group)
Number of subjects: 120
Study: 33734121

Group type: EXPERIMENTAL
Intervention: Valsartan/Amlodipine combination (n=29)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nifedipine GITS monotherapy (n=34)
Number of subjects: 63
Study: 32219622

Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison between Telbivudine and Lamivudine
Number of subjects: 17
Study: 34564759

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 µg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 90
Study: 33594404

Group type: EXPERIMENTAL
Intervention: More diffuse pain (3 or more pain sites)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Less diffuse pain (fewer than 3 pain sites)
Number of subjects: 222
Study: 33087779

Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (5 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (10 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (15 mg kg‐1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet (0 mg kg‐1 Se‐NPs + 0 mg kg‐1 RF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Se‐NPs + RF (all dosages)
Number of subjects: 0
Study: 35022997

Group type: EXPERIMENTAL
Intervention: Contact force-guided catheter ablation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Contact force-blinded catheter ablation
Number of subjects: 150
Study: 34013354

Group type: EXPERIMENTAL
Intervention: Cancer Research UK (CRUK) text‐only video
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Video featuring leading e‐cigarette experts (expert)
Number of subjects: 382

Group type: COMPARATOR
Intervention: No video control condition
Number of subjects: 382
Study: 35112774

Group type: EXPERIMENTAL
Intervention: Increased physical activity (measured in steps per day)
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: High-fat or average-protein diet
Number of subjects: 535

Group type: COMPARATOR
Intervention: Low-fat or high-protein diet
Number of subjects: 535
Study: 34015116

Group type: EXPERIMENTAL
Intervention: Binge alcohol consumption
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fluid control
Number of subjects: 23
Study: 35998848

Group type: EXPERIMENTAL
Intervention: Selective endothelin-A receptor antagonism
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dual endothelin-A/B receptor blockade
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 64
Study: 33549595

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Monitor-only wait list control
Number of subjects: 85
Study: 32532769

Group type: EXPERIMENTAL
Intervention: Nutritional services provided at facilities
Number of subjects: 1467

Group type: COMPARATOR
Intervention: Refugee-hosting facilities
Number of subjects: 1467

Group type: COMPARATOR
Intervention: Non-refugee-hosting facilities
Number of subjects: 1467

Group type: EXPERIMENTAL
Intervention: Good/excellent equipment and store management in outpatient therapeutic centres
Number of subjects: 1467
Study: 36108822

Group type: EXPERIMENTAL
Intervention: +4mm lateralized glenosphere
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard glenospheres
Number of subjects: 102
Study: 33268406

Group type: EXPERIMENTAL
Intervention: Intervention group (restaurants with comprehensive intervention activities for salt reduction)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (restaurants without intervention)
Number of subjects: 192
Study: 34852727

Group type: EXPERIMENTAL
Intervention: UHF‐VR simulation training
Number of subjects: 24

Group type: COMPARATOR
Intervention: cVR simulation training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Stereovision achievement
Number of subjects: 24
Study: 33185269

Group type: EXPERIMENTAL
Intervention: Antenatal couple counselling
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 150
Study: 35690844

Group type: EXPERIMENTAL
Intervention: Spermidine supplementation
Number of subjects: 0
Study: 34329380

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 404

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: No tourniquet
Number of subjects: 404

Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 404
Study: 35394361

Group type: EXPERIMENTAL
Intervention: Stop smoking advice by trained practice assistants after routine cervical screening
Number of subjects: 19
Study: 32216149

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 85
Study: 33166791

Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (aPD‐1/aCTLA‐4) combination treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nivolumab monotherapy (aPD‐1)
Number of subjects: 0
Study: 36253198

Group type: EXPERIMENTAL
Intervention: Robotic-assisted scaphoid screw fixation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional scaphoid screw fixation
Number of subjects: 36
Study: 32851483

Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercise (DBE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 10% of maximal inspiratory pressure (MIP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 60% of maximal inspiratory pressure (MIP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Inspiratory muscle training (IMT) at 30% of maximal inspiratory pressure (MIP)
Number of subjects: 36
Study: 35871357

Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib and dexamethasone (Isa-Kd)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 100
Study: 33471118

Group type: EXPERIMENTAL
Intervention: Nutritional support
Number of subjects: 69934

Group type: COMPARATOR
Intervention: No nutritional support
Number of subjects: 69934
Study: 35852256

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 32997182

Group type: EXPERIMENTAL
Intervention: Positive low-dose computed tomography (LDCT)
Number of subjects: 1248

Group type: EXPERIMENTAL
Intervention: Indeterminate low-dose computed tomography (LDCT)
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Negative low-dose computed tomography (LDCT)
Number of subjects: 1248

Group type: EXPERIMENTAL
Intervention: Increased interval algorithms for screening
Number of subjects: 1248
Study: 36189948

Group type: EXPERIMENTAL
Intervention: 140 mg erenumab
Number of subjects: 0
Study: 34188004

Group type: EXPERIMENTAL
Intervention: Telmisartan, Ramipril, and their combination (exact dosages not specified)
Number of subjects: 30937
Study: 32398149

Group type: EXPERIMENTAL
Intervention: SDM conversation tool
Number of subjects: 183
Study: 35977836

Group type: EXPERIMENTAL
Intervention: ubrogepant-50mg
Number of subjects: 808

Group type: EXPERIMENTAL
Intervention: ubrogepant-100mg
Number of subjects: 808

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 808
Study: 34430837

Group type: EXPERIMENTAL
Intervention: 1790GAHB
Number of subjects: 71

Group type: COMPARATOR
Intervention: GAHB-Placebo
Number of subjects: 71
Study: 35213816

Group type: EXPERIMENTAL
Intervention: Individual exercise and sport counseling based on motives and goals (COMET)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Minimal intervention (written information)
Number of subjects: 129
Study: 32274440

Group type: EXPERIMENTAL
Intervention: Unified Protocol for Emotional Disorders (UP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0
Study: 36284370

Group type: EXPERIMENTAL
Intervention: Goal-based, telehealth-supported programme (n=19)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care (n=19)
Number of subjects: 43
Study: 36097772

Group type: EXPERIMENTAL
Intervention: Original ROI (OROI)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Plus2
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Plus3
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Plus1
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Plus4
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Plus5
Number of subjects: 172
Study: 33106162

Group type: EXPERIMENTAL
Intervention: WBV + exercise (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercise only (n = 12)
Number of subjects: 24
Study: 36463643

Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/day, 3/1-week schedule) plus letrozole (2.5 mg/day)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/day, 3/1-week schedule) plus fulvestrant (500 mg)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo plus endocrine therapy (ET)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Palbociclib plus ET
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo plus ET
Number of subjects: 444
Study: 33952286

Group type: EXPERIMENTAL
Intervention: Individual item-level prediction
Number of subjects: 2858

Group type: EXPERIMENTAL
Intervention: Pessimism
Number of subjects: 2858

Group type: EXPERIMENTAL
Intervention: Network structure at study entry
Number of subjects: 2858

Group type: EXPERIMENTAL
Intervention: Connectivity of networks
Number of subjects: 2858
Study: 36425946

Group type: EXPERIMENTAL
Intervention: Active intermittent theta‐burst stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study: 33098852

Group type: COMPARATOR
Intervention: DNG-only
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EV + DNG
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EE + DNG
Number of subjects: 59
Study: 33870822

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle behavior training based on the Health Promotion Model (HPM)
Number of subjects: 100
Study: 33150427

Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RUL
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RML
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RLL
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for LUL
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for LLL
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Comparison of lobe-specific LN metastasis vs non-lobe-specific LN metastasis
Number of subjects: 1202
Study: 35176727

Group type: EXPERIMENTAL
Intervention: Intermittent low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Initial high volumes followed by low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Progressively increasing volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40
Study: 33274663

Group type: EXPERIMENTAL
Intervention: 0.5 mg lorazepam
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1 mg lorazepam
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32827598

Group type: EXPERIMENTAL
Intervention: Educational messages via WhatsApp sent to parents every 2 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no educational messages)
Number of subjects: 104
Study: 35195484

Group type: EXPERIMENTAL
Intervention: Asthma self-management program
Number of subjects: 126
Study: 33462883

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) plus pemetrexed (500 mg/m2) and cisplatin (75 mg/m2) or carboplatin (AUC 6 mg/mL/min)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chemotherapy alone (PP arm)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus pemetrexed and platinum-based chemotherapy
Number of subjects: 101
Study: 34728531

Group type: EXPERIMENTAL
Intervention: sitagliptin/metformin, insulin glargine and lifestyle therapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 32275198

Group type: EXPERIMENTAL
Intervention: Behavioral intervention involving mindfulness-based practices and empathic collaboration activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 0
Study: 32102812

Group type: EXPERIMENTAL
Intervention: QualDash quality dashboard
Number of subjects: 5
Study: 36188531

Group type: EXPERIMENTAL
Intervention: Light-sedation (L-Group) with bispectral index values kept in the range of 50–59
Number of subjects: 126

Group type: COMPARATOR
Intervention: Deep-sedation (D-Group) with bispectral index values maintained in the range of 40–49
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Light-sedation (L-Group)
Number of subjects: 126
Study: 36315507

Group type: EXPERIMENTAL
Intervention: Written information in patients' own language
Number of subjects: 747

Group type: COMPARATOR
Intervention: Verbal information
Number of subjects: 747
Study: 32354052

Group type: EXPERIMENTAL
Intervention: ICT-based health management services including respiratory and urinary care devices and home visit occupational therapy
Number of subjects: 8
Study: 35131729

Group type: EXPERIMENTAL
Intervention: Superovulation with letrozole, clomiphene, or gonadotropins
Number of subjects: 173
Study: 32773651

Group type: EXPERIMENTAL
Intervention: 4200 IU/week vitamin D
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: 16800 IU/week vitamin D
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: 28000 IU/week vitamin D
Number of subjects: 1257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1257
Study: 33011721

Group type: EXPERIMENTAL
Intervention: Pillcam SB3
Number of subjects: 44

Group type: COMPARATOR
Intervention: OMOM CE
Number of subjects: 44
Study: 33219007

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC) with maintenance classes
Number of subjects: 92
Study: 35466907

Group type: EXPERIMENTAL
Intervention: Mindful parenting intervention
Number of subjects: 7
Study: 34711333

Group type: EXPERIMENTAL
Intervention: MAP ≥75 mm Hg
Number of subjects: 458

Group type: COMPARATOR
Intervention: Control (MAP ≥60 mm Hg)
Number of subjects: 458
Study: 34608532

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - PAT summary provided to patient treating team
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control Group (CG) - No PAT summary provided to treating team
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Subgroup of families in Targeted risk level at T1
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Subgroup of families with Universal risk at T1
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Overall psychosocial risk levels
Number of subjects: 122
Study: 34060300

Group type: EXPERIMENTAL
Intervention: 2-step self-etch adhesive (O-XTR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 3-step etch & rinse adhesive (O-FL)
Number of subjects: 50
Study: 32784794

Group type: EXPERIMENTAL
Intervention: MOD-INT (60% VO2peak, intermittent exercise)
Number of subjects: 12

Group type: COMPARATOR
Intervention: MOD-CON (60% VO2peak, continuous exercise)
Number of subjects: 12

Group type: COMPARATOR
Intervention: LOW-CON (40% VO2peak, continuous exercise)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: LOW-INT (40% VO2peak, intermittent exercise)
Number of subjects: 12
Study: 616864714

Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel (260 mg/m²) combined with pirarubicin (75 mg/m²)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m²) combined with pirarubicin (75 mg/m²)
Number of subjects: 62
Study: 35614875

Group type: EXPERIMENTAL
Intervention: P2X3-receptor antagonist gefapixant
Number of subjects: 0